Online Inquiry

PLGA-PEG-NH2, PEG MW 400-5k

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category PLGA-PEG-NH2
Catalog NO. BPG-1475
Product Name PLGA-PEG-NH2, PEG MW 400-5k
Molecular Formula C12H30N2O5
Molecular Weight Customizable
PLGA-PEG-NH2, PEG MW 400-5k
  • Scheme Design
  • Custom Synthesis
  • cGMP Manufacturing
  • Quality Assurance

Fast track to get specific molecular weight products:

CatalogMolecular WeightAvailability
BPG-1475-1 PLGA-PEG-NH2, PEG MW 400 In stock Inquiry
BPG-1475-2 PLGA-PEG-NH2, PEG MW 600 In stock Inquiry
BPG-1475-3 PLGA-PEG-NH2, PEG MW 1k In stock Inquiry
BPG-1475-4 PLGA-PEG-NH2, PEG MW 2k In stock Inquiry
BPG-1475-5 PLGA-PEG-NH2, PEG MW 3.4k In stock Inquiry
BPG-1475-6 PLGA-PEG-NH2, PEG MW 5k In stock Inquiry
  • Product Information
  • References
  • Documents
  • Reviews

Product Information

Description The compound coupled with polyethylene glycol and polylactic acid-glycolic acid copolymer is a degradable functional high molecular organic compound. PLGA-PEG derivatives with good biocompatibility, non-toxic, good capsular and film forming properties are widely used in pharmaceutical, medical engineering materials and modern industrial fields. PLGA-PEG derivatives can be used as drug-loaded microspheres, vesicles, microcapsules and micelles for sustained release and controlled release of drugs.
Synonyms PLGA-PEG-NH2
IUPAC Name [2-[2-(2-aminoethoxy)ethylamino]-2-oxoethyl] 2-hydroxypropanoate;methane
Canonical SMILES C.C.C.CC(C(=O)OCC(=O)NCCOCCN)O
InChI InChI=1S/C9H18N2O5.3CH4/c1-7(12)9(14)16-6-8(13)11-3-5-15-4-2-10;;;/h7,12H,2-6,10H2,1H3,(H,11,13);3*1H4
InChIKey ZAFPMIYSMXWPRX-UHFFFAOYSA-N
Solubility Soluble in water, DMSO and DMF. Freshly prepared before use.
Storage -20°C for long-term preservation, keep in dry and avoid sunlight. Avoid repeated freezing and thawing.
References 1. Esmaeili F, Ghahremani M H, Ostad S N, et al. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.Journal of drug targeting, 2008, 16(5): 415-423.
2. Aggarwal S, Yadav S, Gupta S. EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer.Journal of biomedical nanotechnology, 2011, 7(1): 137-138.

Reviews

If you have any suggestions or comments about mPEG-Br, please submit a review immediately.

submit

Why BOC Sciences?

  • Large Stock

    More than 2000+ products in inventory

  • Global Delivery

    Warehouses in multiple cities to ensure fast delivery

  • mg to kg

    Multi specification for academic research and industrial production

  • 24/7 Technical Support

    Strict process parameter control to ensure product quality

Products

Resources

Our Feature

BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.

  • Our Feature icon1
  • Our Feature icon2
  • Our Feature icon3
  • Our Feature icon4
PEGylation of Peptides and Proteins

PEGylation of Peptides
and Proteins

Reduce the Immunogenicity of Peptide/Protein Drugs

Learn More

APPLICATIONS

APPLICATIONS

PEG linkers For Drug

Improved Circulation Half-Life

Learn More

Have Customer Reviewed On Us?

logo

Chat With Us

Online Inquiry

Verification code

Copyright © 2024 BOC Sciences. All rights reserved.